Post-Marketing surveillance for the safety of GARDASIL® and GARDASIL®9 in a cohort of Chinese women

First published 10/07/2020

Last updated 02/07/2024

EU PAS number:

EUPAS36132

Study

Finalised

Documents

Study protocol

Initial protocol

V503-055_Redacted Protocol red

English (9.48 MB - PDF) View document

Study results

V503-055 G4 G9 combined_final redaction_0

English (1.09 MB - PDF) View document

V503-055-CSR-HPV PMC G9 Safety Study Report_final redaction

English (789.7 KB - PDF) View document

Study report

Other information

Secondary tabs